Sosyal kuruluşlar için hibeler ve destekler
- 13895
- açık çağrı
- 9
- ülke
- 12
- resmî kaynak
İspanya, Avrupa Birliği ve diğer ülkelerdeki kamu hibe çağrılarını tek yerde topluyoruz. Her kayıtta tutar, gerçek son başvuru tarihi ve kimlerin başvurabileceği yer alır.
Kuruluş türüne göre hibeler
Açık çağrılar
13.895 çağrı · Yakında kapananlar ölçütüne göre sıralandı
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Amerika Birleşik Devletleri · US
Kimler başvurabilir Independent school districts · Special district governments · Private institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · Native American tribal organizations (other than Federally recognized tribal governments) · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · State governments · Public and State controlled institutions of higher education · For profit organizations other than small businesses · City or township governments · Small businesses
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Amerika Birleşik Devletleri · US
Kimler başvurabilir Private institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · State governments · Independent school districts · Public and State controlled institutions of higher education · Small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · City or township governments · For profit organizations other than small businesses · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Special district governments
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer health disparities, such as (1) mechanistic studies of biological factors associated with cancer health disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This NOFO is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
Amerika Birleşik Devletleri · US
Kimler başvurabilir Public housing authorities/Indian housing authorities · State governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · For profit organizations other than small businesses · City or township governments · Native American tribal governments (Federally recognized) · Private institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Special district governments
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to elucidate a role for understudied proteins in rare disease. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s). A list of eligible proteins is provided and are members of druggable protein families that have a known association with a rare disease. This NOFO is intended to jumpstart research on understudied proteins that are associated with rare diseases and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins within the context of rare disease.
EIC Pre-accelerator - Widening
Avrupa Birliği · EU
EIC Pre-accelerator - Widening
Dönem: 5/5/2027 – —
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Amerika Birleşik Devletleri · US
Kimler başvurabilir Small businesses · State governments · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · Independent school districts · For profit organizations other than small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · Private institutions of higher education · Special district governments
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Amerika Birleşik Devletleri · US
Kimler başvurabilir Others (see text field entitled "Additional Information on Eligibility" for clarification)
The purpose of this combined Broad Agency Announcement (BAA) under Federal Acquisition Regulation (FAR) Part 35 and Funding Opportunity Announcement (FOA) under 2 Code of Federal Regulations (CFR) 200.204 (henceforth referred to as “BAA”) is to solicit research proposals for submission to the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL) for funding consideration. Prior to this announcement, ARL announced two separate BAAs to support the mission: 1) W911NF-17-S-0002 titled “Army Research Laboratory Army Research Office Broad Agency Announcement for Fundamental Research”; and 2) W911NF-17-S-0003 titled “Army Research Laboratory Broad Agency Announcement for Basic and Applied Scientific Research”. This announcement succeeds BAA W911NF-17-S-0002 and BAA W911NF-17-S-0003 combining the opportunities into a single announcement. ARL’s mission as the Army’s foundational research laboratory is to Operationalize Science to ensure overmatch in any future conflict. ARL’s foundational research mission spans basic research (budget activity 6.1) and applied research (budget activity 6.2) as defined by 32 CFR 22.105 but may include advanced technology development (budget activity 6.3) and advanced component development and prototypes (budget activity 6.4) when opportunities arise to directly or indirectly help achieve ARL’s mission. ARL partners across the national security enterprise to deliver fundamentally advantageous change that is rooted in the creation and exploitation of scientific knowledge. This publication constitutes a BAA for awards as contemplated in FAR 6.102(d)(2) and 35.016 as well as a merit-based, competitive procedure in accordance with the Department of Defense Grant and Agreement Regulations (DoDGARS) at 32 CFR 22.315(a) and the Office of the Under Secretary of Defense for Acquisition and Sustainment Other Transaction Guide version 2.0 dated July 2023. This BAA document, and the online list of research topics found on the ARL BAA topics website at https://www.arl.devcom.army.mil/opportunities/arl-baa/ , sets forth ARL’s research topics of interest for whitepapers and proposals. This BAA is issued under FAR 6.102(d)(2), which provides for the competitive selection of basic and applied research proposals, and 10 U.S.C. 4001, 10 U.S.C. 4021, and 10 U.S.C. 4022, which provide the authorities for issuing awards under this announcement for basic and applied research. The definitions of basic and applied research may be found at 32 CFR 22.105. Proposals submitted in response to this BAA and selected for award are considered to be the result of full and open competition and in full compliance with the provision of Public Law 98-369, “The Competition in Contracting Act of 1984” and subsequent amendments.
MSCA Doctoral Networks 2027
Avrupa Birliği · EU
MSCA Doctoral Networks 2027
Dönem: 26/5/2027 – —
Demonstration of hydropower technologies for efficient and forward-looking refurbishment of existing hydropower plants
Avrupa Birliği · EU
Demonstration of hydropower technologies for efficient and forward-looking refurbishment of existing hydropower plants
Dönem: 4/8/2027 – —
Industrial processes and equipment for innovative, reliable and scalable tandem technologies (EUPI-PV Partnership)
Avrupa Birliği · EU
Industrial processes and equipment for innovative, reliable and scalable tandem technologies (EUPI-PV Partnership)
Dönem: 4/8/2027 – —
PV based electrification of the economy: Designing & optimising PV systems supporting industrial electrification and promoting participation in electricity markets (EUPI-PV Partnership)
Avrupa Birliği · EU
PV based electrification of the economy: Designing & optimising PV systems supporting industrial electrification and promoting participation in electricity markets (EUPI-PV Partnership)
Dönem: 4/8/2027 – —
Advanced TSO control rooms to enhance grid observability, stability and resilience
Avrupa Birliği · EU
Advanced TSO control rooms to enhance grid observability, stability and resilience
Dönem: 4/8/2027 – —
Advanced Distribution Management Systems (ADSM) for more efficient and flexible distribution grids
Avrupa Birliği · EU
Advanced Distribution Management Systems (ADSM) for more efficient and flexible distribution grids
Dönem: 4/8/2027 – —
Integrated Approaches for Retrofitting Infrastructures with Innovative Energy Storage Technologies
Avrupa Birliği · EU
Integrated Approaches for Retrofitting Infrastructures with Innovative Energy Storage Technologies
Dönem: 4/8/2027 – —
Community of practice - Data-Driven Decision-Making in Energy
Avrupa Birliği · EU
Community of practice - Data-Driven Decision-Making in Energy
Dönem: 4/8/2027 – —
Delivery of industrial CCUS clusters – Societal Readiness pilot
Avrupa Birliği · EU
Delivery of industrial CCUS clusters – Societal Readiness pilot
Dönem: 4/8/2027 – —
Mass customisation of offsite manufactured modular construction components to transform the existing built environment
Avrupa Birliği · EU
Mass customisation of offsite manufactured modular construction components to transform the existing built environment
Dönem: 5/5/2027 – —
Innovative models for collective community investment and ownership
Avrupa Birliği · EU
Innovative models for collective community investment and ownership
Dönem: 5/5/2027 – —
Anticipating the long-term future of neighbourhoods in line with the New European Bauhaus
Avrupa Birliği · EU
Anticipating the long-term future of neighbourhoods in line with the New European Bauhaus
Dönem: 5/5/2027 – —
The transformative potential of co-governance in the green transition of neighbourhoods
Avrupa Birliği · EU
The transformative potential of co-governance in the green transition of neighbourhoods
Dönem: 5/5/2027 – —
Intergenerational neighbourhoods and communities aligned with the New European Bauhaus
Avrupa Birliği · EU
Intergenerational neighbourhoods and communities aligned with the New European Bauhaus
Dönem: 5/5/2027 – —
Novel combinations of knowledge and research methods to address social issues and advance a fair green transition of neighbourhoods
Avrupa Birliği · EU
Novel combinations of knowledge and research methods to address social issues and advance a fair green transition of neighbourhoods
Dönem: 5/5/2027 – —
Combining conventional and innovative construction materials, products and techniques for sustainable and beautiful buildings
Avrupa Birliği · EU
Combining conventional and innovative construction materials, products and techniques for sustainable and beautiful buildings
Dönem: 5/5/2027 – —
Kuruluşunuzun uygun olup olmadığını kontrol edin
Profilinizi oluşturun; Captaru her çağrıyı kuruluşunuza, sektörünüze ve bölgenize göre puanlar. Ayrıca başvuruyu yazmanıza yardım eder.